Cubist Systematic Strategies’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-116,081
Closed -$332K 3395
2024
Q3
$332K Buy
116,081
+21,376
+23% +$59.9K ﹤0.01% 2387
2024
Q2
$265K Buy
94,705
+88,175
+1,350% +$237K ﹤0.01% 2404
2024
Q1
$18.5K Buy
+6,530
New +$22.2K ﹤0.01% 3481
2023
Q3
Sell
-43,946
Closed -$146K 3776
2023
Q2
$146K Sell
43,946
-11,238
-20% -$33.2K ﹤0.01% 2911
2023
Q1
$118K Buy
+55,184
New +$136K ﹤0.01% 3408
2022
Q4
Sell
-37,713
Closed -$122K 4507
2022
Q3
$122K Sell
37,713
-177,567
-82% -$802K ﹤0.01% 3951
2022
Q2
$1.05M Sell
215,280
-67,045
-24% -$413K 0.01% 2442
2022
Q1
$2.15M Buy
282,325
+246,660
+692% +$1.91M 0.02% 1412
2021
Q4
$330K Buy
35,665
+17,114
+92% +$182K ﹤0.01% 2739
2021
Q3
$264K Sell
18,551
-171,631
-90% -$2.67M ﹤0.01% 2431
2021
Q2
$3.16M Buy
190,182
+65,537
+53% +$1.22M 0.04% 800
2021
Q1
$2.27M Buy
124,645
+87,016
+231% +$1.18M 0.03% 939
2020
Q4
$283K Buy
+37,629
New +$179K ﹤0.01% 2067

Other funds holding ORGO

Cubist Systematic Strategies's ORGO Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 116,081 shares — an estimated $332K sold.

Cubist Systematic Strategies first reported a position in ORGO in Q4 2020 and held it in 13 quarters. The position peaked at $3.16M in Q2 2021. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

  • Cubist Systematic Strategies reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 116,081 Organogenesis Holdings shares in Q4 2024, an estimated $332K.
  • Cubist Systematic Strategies first reported a position in Organogenesis Holdings in Q4 2020 and held it in 13 quarters.
  • Cubist Systematic Strategies's Organogenesis Holdings position peaked at $3.16M in Q2 2021.
  • 120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.